First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex Bluejay Therapeutics has enrolled the first patient...
Medicine
New partnership aims to fast-track mRNA therapies from lab to clinic Quotient Sciences and CPI have signed...
Novel orexin receptor agonist shows potential to improve wakefulness Eisai has presented new clinical data for its...
Sharon Curran has been appointed Chair of Rosemont’s board Sharon Curran has been appointed as the new chairperson for Rosemont Pharmaceuticals board...
Trial explores regenerative macrophage therapy for liver disease Resolution Therapeutics has announced that the first patient has...
Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain lzeCure Pharma has presented new clinical data on...
Survey reveals lack of awareness need for greater clarity
Blended solutions gain momentum and reveal untapped potential
Collaboration offers end-to-end support from donor sourcing to manufacturing eXmoor Pharma and Anthony Nolan: Cell Therapy &...
Deal covers biosimilars for gastroenterology, neurology and dermatology Polpharma Biologics has signed licensing agreements with MS Pharma...
MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma Eli Lilly and Company has received conditional...
New subcutaneous autoinjector offers at-home treatment option for patients Eisai and Biogen have announced FDA approval of...
The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application from Coya...
Swedish biotech company Akiram Therapeutics has announced significant progress in its first clinical trial of AKIR001, a...
HUTCHMED has announced that Weiguo Su, CEO of the company, will take a leave of absence from...
Encare’s ERAS Interactive Audit System (EIAS) has earned qualification on the Mayo Clinic Platform_Solutions Studio – a...
Eli Lilly and Company has announced that Anne White, executive vice president and president of Lilly Neuroscience,...
Novartis has reported that its experimental drug ianalumab met the primary goal in a phase 3 trial...
Top-rated pharmacies in northern Virginia for personalised fertility care Finding the right pharmacy to support your fertility...
Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, to develop...
ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating tumour cell (CTC) DNA harvested...
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan (iza-bren),...
Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call to support...
Project aims to improve global immunisation through needle-free delivery Upperton Pharma Solutions has secured funding from the...
Merck’s therapy becomes first authorised option for aggressive soft tissue tumours Merck has announced that the European...
Nationwide competition to pilot new models of obesity support Eli Lilly and Company and the UK Government...
Lilly’s study finds tirzepatide delivers broader health improvements Eli Lilly has announced positive topline results from its...
Company shifts focus to phase 3 VE303 trial in recurrent C. difficile infection Vedanta Biosciences has announced...
Promising results support global submissions and priority review by US FDA Genmab has announced that its phase...
Teva’s CGRP therapy becomes first approved option for children and adolescent Teva Pharmaceuticals has received US FDA...
Pirtobrutinib meets primary endpoint in CLL/SLL study Eli Lilly and Company has announced positive topline results from...
New treatment option now available across all UK nations Patients in Scotland with relapsed or refractory mantle...
New phase of development targets chronic pain and fibromyalgia Sever Pharma Solutions has deepened its partnership with...
Celltrion’s biosimilar now fully aligned with ACTEMRA IV indications in US Celltrion has received US Food and...
New first-line option for patients with pMMR and dMMR tumours in England NICE has recommended KEYTRUDA (pembrolizumab)...
FDA validation and AI-designed therapies mark major shift in treatment strategy Porosome Therapeutics has announced major advances...
New oral GLP-1 agonist aims to reshape chronic weight management Nxera Pharma has launched a broad proprietary...
Dydrogesterone-only tablet returns after 17-year absence to support personalised care Gedeon Richter UK has launched Nalvee (10mg...
New drug delivery system could transform treatment for chronic conditions Scientists at the University of Bath have...
MB310 study investigates safety and efficacy of precision microbiome therapy Microbiotica has completed patient recruitment for its...
US$30.9 million strategic equity deal strengthens oncology platform Everest Medicines has announced a strategic equity investment of...
Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season Moderna has received marketing authorisation from the...
Four-year treatment slows cognitive decline with consistent safety profile Eisai has presented new clinical data showing that...
Imfinzi and Imjudo combination recommended as first-line treatment AstraZeneca has received a positive recommendation from NICE for...
Alfasigma to seek regulatory approval following OLINGUITO study success Alfasigma has announced positive topline results from its...
Still time to enter – but not much! Enter The 2025 PharmaTimes Clinical Researcher of the Year...
CLEAR-DE study to assess topical therapy for non-proliferative diabetic retinopathy Exonate has announced plans to initiate a...
Veranova has appointed Elizabeth Rebeil as VP of Supply Chain Excellence Veranova has appointed Elizabeth Rebeil as Global Vice President of Supply Chain...
CHMP recommends authorization for LP.8.1-targeting vaccine ahead of 2025-2026 season Moderna has received a positive opinion from...
Collaboration aims to advance next-generation therapeutics and vaccines Kling Bio has announced a new collaboration and licence...
Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator payload used...
Irish biotech’s germ-free egg platform could help close global shortfall Irish biotech Ovagen has announced a major...
First patient dosed in phase 1b/2a study of procizumab 4TEEN4 Pharmaceuticals has dosed the first patient in...
Enter this year’s thrilling competition! Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas!...
GlueSEEKER enables rational design of targeted protein degraders PhoreMost has published new data validating its GlueSEEKER platform,...
EC grants conditional marketing authorisation to Merck and SpringWorks Therapeutics The European Commission has approved EZMEKLY (mirdametinib)...
Clinical results from phase 2 study highlight analgesic effects in neuropathic pain patients AlzeCure Pharma will present...
Funding to accelerate development of AI-driven tumour profiling tool OneMap One Biosciences has secured €15 million in...
First patient dosed in BUOY-1 study targeting MDD with or without anxious distress Seaport Therapeutics has dosed...
Digital operating rooms and histotripsy therapy combine to improve outcomes Proximie has announced a new partnership with...
Healthinote rollout aims to improve early detection and patient self-management North East and North Cumbria NHS has...
Sebetralstat offers injection-free relief for patients aged 12 and over The MHRA has approved sebetralstat (Ekterly) as...
Vertex’s once-daily triple therapy approved for eligible patients aged six and over Vertex Pharmaceuticals has announced a...
Researchers at Imperial College London have discovered that an unusual DNA structure could be key to reversing...
New treatment targets BRAFV600E-mutant mCRC after prior therapy Pierre Fabre Laboratories have received marketing authorisation in China...
OVX836 shown to be safe and effective alongside seasonal Fluarix Tetra Osivax has released phase 2a trial...
New regulations aim to simplify processes and strengthen patient safety The Government is set to amend UK...
Funding to support lead candidate targeting FAP and pipeline expansion Actithera has secured $75.5 million in an...
BX004 achieves 500-fold bacterial reduction with no resistance in phase 1b/2a study BiomX has published promising phase...
Enter the 2025 PharmaTimes Clinical Researcher of the Year – The Americas Enter The 2025 PharmaTimes Clinical...
New trial to test VMX-C001’s effectiveness in restoring coagulation in FXa DOAC patients Biotech company VarmX has...
SMC approval provides option for postmenopausal women at risk of fractures The Scottish Medicines Consortium has recommended...
PulseSight begins phase 1 safety study of gene therapy for geographic atrophy PulseSight Therapeutics has announced that...
CSL Behring marks new era in treatment with milestone reimbursement model The first haemophilia B patient in...
Clinigen has appointed Paul Carter as Non-Executive Chair of its Board Clinigen, the global pharmaceutical services Group, has...
Pneumagen’s intranasal antiviral demonstrates reduced infection Pneumagen has announced the publication of phase 2 data showing its...
Enhanced Genomics appoints Dr Dietrich Stephan as Chair of the Board Enhanced Genomics has appointed Dr Dietrich Stephan as Chair of...
Data shows mRNA-1010 could better protect adults aged 50 and above Moderna has reported positive phase 3...
Closed Loop Medicine has appointed Kate Woolland as CEO Closed Loop Medicine (CLM) has appointed Kate Woolland as Chief Executive...
New data show strong efficacy of CD388 in phase 2b trial Cidara Therapeutics and hVIVO have announced...
Positive trial results offer hope for those with ultra-rare epileptic disorder UCB has announced that its phase...
Transforming community prescribing through innovation As the NHS places an increasing focus on strengthening primary care and...
Why supporting representative trial participation matters
This year’s event took place on 11 to 12 June at Manchester Central This year’s NHS ConfedExpo...
VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer. In this newly...
Enter this year’s famous competition Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas!...
The programme was unveiled at this year’s NHS ConfedExpo in Manchester PMGroup Worldwide and Visions4Health have launched...
Biocartis has appointed Ben Svarczkopf as Senior Vice President of Global Marketing Biocartis Group of Companies (Biocartis)...
The pilot will see GP practices look at patient records to identify those most at risk The...
Kallikor has appointed Chris Brett as Chief Technology and Product Officer Kallikor has announced the appointment of...
Signadori is advancing a platform designed to overcome the challenges of treating solid cancers eXmoor Pharma and...
Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer Aravax has announced the appointment of...
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab Teva Pharmaceutical Industries and...
iOnctura has appointed Steven Sciuto as Chief Financial Officer iOnctura has announced the appointment Steven Sciuto as...
Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US The US Food and Drug...
Results suggest bispecific antibody combination could improve outcomes A new investigational treatment has shown strong and lasting...
Collaboration aims to improve rapid detection and personalised treatments EDX Medical Group has entered into an agreement...
Tozaro has appointed Dr Jason Slingsby as Chief Executive Officer Tozaro has announced the appointment of Dr Jason Slingsby as Chief Executive Officer....
Rheumatology studies show promising results for Sjogren’s disease Argenx has presented positive phase 2 results for efgartigimod...
EMHA calls for its inclusion in EU neurological health strategy The European Migraine and Headache Alliance (EMHA)...
Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data from its...
Three-year data highlights inflammation control in psoriatic arthritis UCB has announced new three-year data from phase 3...
Personalisation is the future of cancer care
Biotech firm to collaborate with NHS on early detection study Tagomics has been awarded £860k in funding...
Clinigen has appointed Nihad Hasagic as SVP for CLS Clinigen has appointed Nihad Hasagic as Senior Vice President for Clinigen Lifecycle Services (SVP...
Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas! Enter The 2025 PharmaTimes Clinical...
Tozaro has announced the appointment of Dr Jason Slingsby as Chief Executive Officer. Jason will lead the company’s long-term strategy,...
New funding supports development of diagnostic platform Birmingham spin-out Linear Diagnostics has secured £1m funding to advance...
Therapy indicated for children aged 3 to 14 at treatment initiation Santen has announced that the European...
Treatment provides option for children with growth failure The National Institute for Health and Care Excellence (NICE)...
Last month, I had the privilege of hosting a webinar for the National Institute for Health and...
Richard Condon, CEO Aspire Pharma, discusses successful leadership
Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas! Enter The 2025 PharmaTimes Clinical...
Updated guidance from NICE expands eligibility for dapagliflozin us The National Institute for Health and Care Excellence...
New guidance expands treatment options for eligible patients The National Institute for Health and Care Excellence (NICE)...
Worldwide Clinical Trials has appointed Stephen Rayda as Chief Digital and Information Officer Worldwide Clinical Trials has...
The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise Lumanity and the...
Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines...
TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share...
Company secures regulatory approvals for commercial rollout in UK and US With over 55 million people worldwide...
First non-immunosuppressive dual-action therapy approved for eligible patients The National Institute for Health and Care Excellence (NICE)...
Strategic collaboration aims to improve early diagnosis Sonrai Analytics and AOA Dx have announced a partnership to...
The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the...
Kelso Pharma has appointed Bee Koen Low as Chief Operating Officer Kelso Pharma has announced the appointment...
The drug was recently approved in the US for familial chylomicronaemia syndrome Ionis Pharmaceuticals has shared positive...
Veranova has appointed Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence Veranova has...
Brekiya is now the first DHE auto-injector to be approved by the regulator The US Food and...
Regulator confirms safety and efficacy of new treatment option for patient The Medicines and Healthcare products Regulatory...
Biotech spin-off targets fibrosis, neoplasm and neovascularization Massalia Therapeutics, a biotechnology spin-off from the C2VN Institute, has...
Aspire-FTD study aims to stop disease progression with one-time treatment AviadoBio has launched its phase 1/2 Aspire-FTD...
Asgard Therapeutics has appointed Shane Olwill as Chief Development Officer Asgard Therapeutics, a privately held biotech company pioneering in...
FDA recognises KER-0193 as a potential therapy for rare paediatric disease Kaerus Bioscience has received orphan drug...
Trial progresses towards topline data expected later in the year Herantis Pharma has dosed the first patients...
Screening begins for study evaluating LTI-03 in idiopathic pulmonary fibrosi Rein Therapeutics has begun screening and recruiting...
Ellab has appointed Gergely Sved as its new Chief Executive Officer Ellab, the provider of validation, monitoring and calibration...
Private equity firm Apiary Capital backs rapid growth of performance-i Apiary Capital has completed its investment in...
Fiona Smith-Laittan has been appointed Chair of Cambridge Global Health Partnerships Fiona Smith-Laittan, Vice President of Global...
Study explores whether PI3Kδ targeting could combat resistance iOnctura has begun a randomized phase 1/2 study investigating...
Teprotumumab approved as first targeted treatment for thyroid eye disease The UK’s Medicines and Healthcare products Regulatory...
Demonstrate your skill and prowess by entering this year’s awards! For 2025, The 2025 PharmaTimes Clinical Researcher...
UCB’s developmental treatment may be eligible for patient access UCB has announced that its developmental treatment DoxTM,...
Company seeks approval for new schedules to improve patient convenience Janssen-Cilag International NV, a Johnson & Johnson...
New initiative aims to accelerate diagnosis and ease NHS pressures Chiesi UK and Ireland and Wirral Primary...
Cambridge firm in-licenses two oncology programmes Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed...
Approval marks milestone for AI use in frontline care NICE has endorsed DERM, an autonomous AI medical...
Application seeks reduced infusion frequency to support patient flexibility Eisai Europe and Biogen Idec have announced the...
Aspire Pharma has appointed Katharina Pink as Chief Commercial Officer Aspire Pharma has announced the appointment of...
New therapy offers hope for patients with limited option Regeneron Pharmaceuticals has announced that the European Commission...
Study paves the way for personalised therapies for osteoarthritis sufferer Groundbreaking research has identified over 900 genetic...
Today’s leaders are building a stronger, more inclusive future for the industry
CHMP recommendation brings new hope for patients Takeda has announced a positive opinion from the Committee for...
VYVGART could be the first CIDP drug with a novel mechanism in 30 years Argenx has announced...
Kymera Therapeutics has appointed Noah Goodman as Chief Business Officer Clinical-stage biopharma Kymera Therapeutics has announced the...
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK Researchers from University...
MHRA authorises drug for adults with rare heart muscle damage The Medicines and Healthcare products Regulatory Agency...
Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes from Astex...
Where to purchase reliable pharmacy automation systems Technological advancements propel the pharmaceutical industry into the future. Better...
Terumo BCT has appointed Patrick Daly as Chief Business Officer Terumo Blood and Cell Technologies (Terumo BCT)...
It is hoped that the MAGIC-I study will support earlier diagnosis and personalised treatment A five-year clinical...
ABPI has appointed Russell Abberley as President-elect The Association of the British Pharmaceutical Industry (ABPI) has appointed...
The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine Novavax has shared positive preliminary...
Oncodesign Services has appointed Aidan Synnott as CEO Oncodesign Services has announced the appointment of Aidan Synnott...
More than 37 million adults in the US are affected by migraine The US Food and Drug...
New real-world data reinforce treatment benefit Real-world data from the University of Catania, Italy, suggest that Pepaxti,...
European Commission grants authorisation for Eisai and Biogen therapy The European Commission has granted marketing authorisation for...
Studies show improved bone mineral density and healthcare cost reductions New data from multiple countries confirm the...
Long-term survival projections suggest improved outcomes for patients New data from Janssen-Cilag International NV suggest that subcutaneous...
Birmingham researchers to make MGUS monitoring more efficient Birmingham researchers have received £230k from Cancer Research Horizons...
Major update aims to accelerate research and strengthen patient safety New UK clinical trials regulations have been...
The model could lead to more targeted treatments for the disease Cancer Research scientists have developed a...
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic...
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making SkyCell has partnered with Microsoft to launch...
An estimated 7.5 million people will be invited to receive the booster The NHS has started delivering...
Angelini Ventures has appointed Regina Hodits as managing director Angelini Ventures has announced the appointment of Regina...
Approximately 55,100 new cases of prostate cancer are diagnosed every year in the UK The Medicines and...
The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa...
Research targets lysosomal function restoration for neurodegeneration Endlyz Therapeutics has launched from stealth, unveiling its pipeline of...
Women are shaping new dimensions throughout industry Having women in the pharmaceutical industry is crucial because it...
Women in healthcare and pharma – progress, challenges and outcomes
Collaboration introduces automation to enhance efficiency Elekta has announced a partnership with Azra AI to improve cancer...
Approval extends ustekinumab’s use to younger patients The European Commission (EC) has approved ustekinumab for the treatment...
Advancing care for stage 3 or 4 Hodgkin lymphoma patients The National Institute for Health and Care...
GMP certification enables 4basebio to supply DNA for clinical trials 4basebio PLC has been granted Good Manufacturing...
Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath...
Are biotechs underestimating regulatory groundwork
The vital link between human and animal well-being The next pandemic will require crucial collaboration between veterinarians...
When Integrated DNA Technologies (IDT) launched its Collab Network in February 2023, the goal was to speed...
Janssen drug combination extends life expectancy during trial Janssen-Cilag International NV has announced results from the phase...
New therapy developed to repair GJB2 R75W mutation Scientists from Juntendo University and The University of Tokyo...
NOUS-209 shows potential to intercept cancer in its early stages Nouscom has announced full safety and immunogenicity...
Drug Safety Research Unit appoints Linda Härmark as its Director The Drug Safety Research Unit has announced Linda Härmark as its new...
Sygnature Discovery has appointed Kieron Hall as Chief Commercial Officer Sygnature Discovery has announced the appointment of Kieron Hall as its new Chief...
Nuclera has appointed Seth Benson as Chief Financial Officer Nuclera, the biotechnology company accelerating protein expression and optimisation through...
iOnctura has appointed Elizabeth Holt as Chief Business Officer iOnctura has announced the appointment of Elizabeth Holt,...
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants The World Health Organization (WHO) has announced...
Collaboration brings remote care to cancer patients Careology and Entia have announced a partnership to enhance cancer...
VIDAR-1 trial marks company’s clinical-stage debut Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1,...
Aragen has appointed Manjunath Ramarao as Chief Scientific Officer Aragen has announced the appointment of Manjunath Ramarao...
The update is aimed at strengthening local and national surveillance The UK Health Security Agency (UKHSA) has...
Elekta has appointed Jonas Bolander as Acting President and CEO Elekta has announcement the appointment of Jonas...
